Efficacy and Safety Evaluation in Recurrent Wheezing Attacks

Inclusion Criteria: * Subjects whose parents /legal representative have given written informed consent. * Both gender * Subject up to 36 months of age. * Subjects with recurrent bronchospasms (wheezing attacks); 3 or more exacerbations in the last 12 months Exclusion Criteria: * Subjects whose parents/legal representative have not given written informed consent. * Subjects out of aged range * Subjects with malignancies or chemotherapy treatment * Subjects included in another clinical trial in the last 12 months. * Subject in immunosuppressive or immunostimulatory treatment * Subjects who have received iv gamma globulin in the past 12 months. * Subjects diagnosed with candidiasis or fungal recurrent infections. * Subjects diagnosed with malabsorption syndrome * Subjects with clinical allergy to common aeroallergens in the geographical area. * Subjects with hepatitis virus infections, HIV and tuberculosis